TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome

TNF 过度产生会损害高 IgE 综合征中上皮细胞对葡萄球菌的反应。

阅读:8
作者:Ian A Myles ,Erik D Anderson ,Noah J Earland ,Kol A Zarember ,Inka Sastalla ,Kelli W Williams ,Portia Gough ,Ian N Moore ,Sundar Ganesan ,Cedar J Fowler ,Arian Laurence ,Mary Garofalo ,Douglas B Kuhns ,Mark D Kieh ,Arhum Saleem ,Pamela A Welch ,Dirk A Darnell ,John I Gallin ,Alexandra F Freeman ,Steven M Holland ,Sandip K Datta

Abstract

Autosomal dominant hyper IgE syndrome (AD-HIES), or Job's syndrome, is a primary immune deficiency caused by dominant-negative mutations in STAT3. Recurrent Staphylococcus aureus skin abscesses are a defining feature of this syndrome. A widely held hypothesis that defects in peripheral Th17 differentiation confer this susceptibility has never been directly evaluated. To assess the cutaneous immune response in AD-HIES, we induced suction blisters in healthy volunteers (HVs) and patients with AD-HIES and then challenged the wound with lethally irradiated bacteria. We show that cutaneous production of IL-17A and IL-17F was normal in patients with AD-HIES. Overproduction of TNF-α differentiated the responses in AD-HIES from HVs. This was associated with reduced IL-10 family signaling in blister-infiltrating cells and defective epithelial cell function. Mouse models of AD-HIES recapitulated these aberrant epithelial responses to S. aureus and involved defective epithelial-to-mesenchymal transition (EMT) rather than a failure of bacterial killing. Defective responses in mouse models of AD-HIES and primary keratinocyte cultures from patients with AD-HIES could be reversed by TNF-α blockade and by drugs with reported modulatory effects on EMT. Our results identify these as potential therapeutic approaches in patients with AD-HIES suffering S. aureus infections. Keywords: Immunology; Immunotherapy; Infectious disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。